Background: The association between caffeine and cognitive performance has not been tested in older individuals with type 2 diabetes (T2D). Its association with brain volume in T2D has been tested only in animals. Methods: We examined the association of caffeine with cognitive function and brain volume in a sample of elderly diabetics participating in the Israel Diabetes and Cognitive Decline Study (n = 638) and the moderating effect of age on this association. In a subsample (n = 185) with magnetic resonance imaging, we also examined these associations with gray and white matter volumes (GM/WM). Results: Using linear regression adjusting for cognition-related covariates, we found that higher caffeine intake was associated with better function in overall cognition (p =.018), attention/working memory (p =.002), executive functioning (p =.047), and semantic categorization (p =.026). Interaction analyses of caffeine intake with age were significant for semantic categorization (p =.025), and approached significance for overall cognition (p =.066). This association was driven by the older group (above-median) for whom the association of caffeine intake with semantic categorization (p =.001), attention/working memory (p =.007), executive functioning (p =.005), and overall cognition (p =.002) were significant. In the magnetic resonance imaging subsample, there was an interaction (p =.034) of caffeine intake with age for GM volume; in the older group, higher caffeine intake was associated with greater GM volume (β =.198, p =.033). Conclusions: Caffeine intake may have a beneficial role in cognitive functioning of elderly adults with T2D, which may be moderated by age. Greater GM volume may be a mechanism underlying the association of higher caffeine intake with better cognitive function.
|Number of pages||6|
|Journal||Journals of Gerontology - Series A Biological Sciences and Medical Sciences|
|State||Published - 1 May 2019|
- Cognitive aging
- Type 2 diabetes
ASJC Scopus subject areas
- Geriatrics and Gerontology